Search Results - "Androulakis, Nikos"

Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients by XENIDIS, Nikos, PERRAKI, Maria, CHRISTOPHYLAKIS, Charalambos, ARGYRAKI, Katerina, LIANIDOU, Evi S, STATHOPOULOS, Stathis, GEORGOULIAS, Vassilis, MAVROUDIS, Dimitris, KAFOUSI, Maria, APOSTOLAKI, Stella, BOLONAKI, Irene, STATHOPOULOU, Aliki, KALBAKIS, Kostas, ANDROULAKIS, Nikos, KOUROUSSIS, Charalambos, PALLIS, Thanos

“…To evaluate the predictive and prognostic value of peripheral blood cytokeratin-19 (CK-19) mRNA-positive cells in axillary lymph node-negative breast cancer…”
Get full text

Present Treatment and Future Expectations in Advanced Pancreatic Cancer by STATHOPOULOS, George P, ANDROULAKIS, Nikos, SOUGLAKOS, John, STATHOPOULOS, John, GEORGOULIAS, Vassilis

“…Advanced or metastatic pancreatic cancer is an incurable disease. The main treatment is chemotherapy with cytotoxic agents. On the basis of our experience in…”
Get full text

Front-Line Treatment of Advanced Non–Small-Cell Lung Cancer With Docetaxel and Gemcitabine: A Multicenter Phase II Trial by GEORGOULIAS, V, KOUROUSSIS, C, HATZAKIS, K, KALBAKIS, K, KOTSAKIS, A, VARDAKIS, N, VLACHONICOLIS, J, ANDROULAKIS, N, KAKOLYRIS, S, DIMOPOULOS, M.-A, PAPADAKIS, E, BOUROS, D, APOSTOLOPOULOU, F, PAPODIMITRIOU, C, AGELIDOU, A

“…To evaluate the tolerance and efficacy of the combination of docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer (NSCLC). Fifty-one…”
Get full text

Treatment of Pancreatic Cancer With Docetaxel and Granulocyte Colony-Stimulating Factor: A Multicenter Phase II Study by ANDROULAKIS, N, KOUROUSIS, C, STATHOPOULOS, G. P, GEORGOULIAS, V, DIMOPOULOS, M. A, SAMELIS, G, KAKOLYRIS, S, TSAVARIS, N, GENATAS, K, ARAVANTINOS, G, PAPADIMITRIOU, C, KARABEKIOS, S

“…To determine the efficacy and tolerance of single-agent docetaxel and granulocyte colony-stimulating factor in patients with advanced pancreatic cancer…”
Get full text

Dose-Escalation Study of Docetaxel in Combination With Mitoxantrone as First-Line Treatment in Patients With Metastatic Breast Cancer by KOUROUSSIS, C, ANDROULAKIS, N, VLACHONIKOLIS, J, GEORGOULIAS, V, KAKOLYRIS, S, SOUGLAKOS, J, KOTSAKIS, T, MAVROUDIS, D, KATSOGRIDAKIS, K, VARDAKIS, N, HATZIDAKI, D, SAMONIS, G

“…To define the maximum-tolerated dose (MTD) and the dose-limiting toxicities (DLTs) of docetaxel in combination with mitoxantrone in patients with metastatic…”
Get full text

Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group by Pistamaltzian, Nikolaos, Tzannis, Kimon, Pissanidou, Vassiliki, Peroukidis, Stavros, Milaki, Georgia, Karavasilis, Vasilis, Mitsogiannis, Iraklis, Varkarakis, Ioannis, Papatsoris, Athanasios, Dellis, Athanasios, Adamakis, Ioannis, Stravodimos, Konstantinos, Molyva, Dimitra, Athanasiadis, Ilias, Androulakis, Nikos, Andreadis, Charalambos, Kalofonos, Charalambos, Mitropoulos, Dionisios, Deliveliotis, Charalambos, Constantinides, Constantinos, Dimopoulos, Meletios A, Bamias, Aristotelis

“…Relapsed urothelial cancer represents an unmet medical need. Vinflunine is a third-generation antimicrotubuline inhibitor and is currently the only approved…”
Get full text

Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG) by Bamias, Aristotle, Peroukidis, Stavros, Stamatopoulou, Sophia, Tzannis, Kimon, Koutsoukos, Konstantinos, Andreadis, Charalambos, Bozionelou, Vasiliki, Pistalmatzian, Nikos, Papatsoris, Athanasios, Stravodimos, Konstantinos, Varthalitis, Ioannis, Karamouzis, Michalis, Milaki, Georgia, Agorastos, Antonios, Kentepozidis, Nikos, Androulakis, Nikos, Bompolaki, Iliada, Kalofonos, Haralampos, Mavroudis, Dimitrios, Dimopoulos, Meletios A

“…Micro-Abstract Advanced urothelial cancer (AUCa) is associated with poor long-term survival due to nonexposure to cisplatin-based chemotherapy and poor outcome…”
Get full text

Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status by Souglakos, John, Vamvakas, Lambros, Apostolaki, Stella, Perraki, Maria, Saridaki, Zacharenia, Kazakou, Irine, Pallis, Athanasios, Kouroussis, Charalambos, Androulakis, Nikos, Kalbakis, Kostas, Millaki, Georgia, Mavroudis, Dimitris, Georgoulias, Vassilis

“…To evaluate the incidence of central nervous system (CNS) involvement in patients with breast cancer treated with a taxane-based chemotherapy regimen and to…”
Get full text

NSCLC—platinum or not by Androulakis, Nikos, Georgoulias, Vassilis

Get full text

Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy : A report of five cases by KOUROUSSIS, C, SAMONIS, G, ANDROULAKIS, N, SOUGLAKOS, J, VOLOUDAKI, A, DIMOPOULOS, M.-A, KOTSAKIS, T, KAKOLYRIS, S, KALBAKIS, K, GEORGOULIAS, V

“…Five cases of acute neutropenic enterocolitis complicating taxane-based chemotherapy are described. During a 34-month period, our department administered 4,600…”
Get full text

Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study by Agelaki, Sophia, Bania, Helen, Kouroussis, Charalambos, Blazoyiannakis, George, Souglakos, John, Tsiafaki, Xanthi, Kalbakis, Kostas, Rapti, Ageliki, Androulakis, Nikos, Georgoulias, Vassilis, Papadakis, Emmanuel

“…Objective: A phase II study was conducted to evaluate the efficacy and toxicity of vinorelbine–carboplatin (VNB–C) combination as a salvage treatment in…”
Get full text

A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors by KOUROUSSIS, Charalambos, KAKOLYRIS, Stelios, GEORGOULIAS, Vassilis, MAVROUDIS, Dimitris, ANDROULAKIS, Nikos, KALBAKIS, Kostas, AGELAKI, Sofia, SARRA, Evi, SOUGLAKOS, John, CHRISTODOULAKIS, Manousos, SAMONIS, George

“…The purpose of this study was to determine the dose-limiting toxicities and the maximum-tolerated dose (MTD) of weekly administration of paclitaxel in patients…”
Get full text

Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer : A multicenter phase II study of the Greek Cooperative Group for Lung Cancer by GEORGOULIAS, V, ANDROULAKIS, N, HATZIDAKI, D, VLACHONIKOLIS, J, PANAGOS, G, BOUROS, D, KOUROUSSIS, C, CHATZAKIS, K, PAPADAKIS, M, APOSTOPOLOULOU, F, GEORGOPOULOU, T, KOTSAKIS, T, SOUKLAKOS, J

“…Vinorelbine, docetaxel and cisplatin have documented single-agent activity in non-small-cell lung cancer (NSCLC); a multicenter phase II trial was initiated in…”
Get full text

Vinorelbine-based regimens as salvage treatment in patients with advanced non-small cell lung cancer: two parallel multicenter phase II trials by Agelaki, S, Bania, H, Kouroussis, C, Blazoyiannakis, G, Souglakos, J, Tsiafaki, X, Harpidou, A, Kalbakis, K, Rapti, A, Androulakis, N, Sarra, E, Georgoulias, V, Papadakis, E

“…Two parallel phase II trials were conducted in order to evaluate the efficacy and toxicity of vinorelbine-ifosfamide (VNB-IFX) and vinorelbine-carboplatin…”
Get more information

nCombination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: A multicenter phase II study of the Greek Cooperative Group for Lung Cancer by Georgoulias, Vassilis, Androulakis, Nikos, Bouros, Demosthenis, Kouroussis, Charalampos, Chatzakis, Kostas, Papadakis, Manolis, Apostopoloulou, Fotini, Georgopoulou, Theoni, Kotsakis, Thanos, Souklakos, John, Hatzidaki, Dora, Vlachonikolis, John, Panagos, Gerassimos

“…Vinorelbine, docetaxel and cisplatin have documented single-agent activity in non-small-cell lung cancer (NSCLC); a multicenter phase II trial was initiated in…”
Get full text

First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin by KAKOLYRIS, S, KOUROUSIS, C, KOUKOURAKIS, M, ANDROULAKIS, N, VAMVAKAS, L, AGELAKI, S, HATZIDAKI, D, SAMONIS, G, TSIFTSIS, D, GEORGOULIAS, V

“…A phase II trial was conducted with mitoxantrone (12 mg/m2, day 1), vinorelbine (30 mg/m2, day 1), and carboplatin (250 mg/m2, day 2) every 21 days. Fifty…”
Get full text